ES471594A1 - Procedimiento para la preparacion de alfa-halometil deriva- dos de amino acido - Google Patents

Procedimiento para la preparacion de alfa-halometil deriva- dos de amino acido

Info

Publication number
ES471594A1
ES471594A1 ES471594A ES471594A ES471594A1 ES 471594 A1 ES471594 A1 ES 471594A1 ES 471594 A ES471594 A ES 471594A ES 471594 A ES471594 A ES 471594A ES 471594 A1 ES471594 A1 ES 471594A1
Authority
ES
Spain
Prior art keywords
straight
carbon atoms
hydrogen
branched
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES471594A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merrell Toraude et Cie
Original Assignee
Merrell Toraude et Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Toraude et Cie filed Critical Merrell Toraude et Cie
Publication of ES471594A1 publication Critical patent/ES471594A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Procedimiento para la preparación de alfahalometil derivados de amino ácido, especialmente derivados de histidina y compuestos relacionados, farmaceúticamente útiles. La mayor parte del tejido de los mamíferos contiene histamina, siendo la concentración particularmente alta en la piel, en la mucosa intestinal y en los pulmones. Todo tejido de mamíferos, que contiene histamina, incluyendo las células sanguíneas blancas, aparece como capaz de sintetizar la amina de histidina. La principal enzima, comprendida en la catalización en vivo de la conversión de histidina en histamina, es decarboxilasa de histidina, que es específica para el substrato L-histidina. En muchos tejidos el principal lugar de almacenaje de histamina es la célula de mástil, o en el caso de sangre, el basófilo que es la contrapartida circulante de la célula de mástil de tejido. Las células de mástil no son la única fuente de tejido de histamina, que está presente en cantidades sustanciales en la epidermis humana, el sistemanervioso central y la mucosa gastrointestinal.
ES471594A 1977-07-28 1978-07-10 Procedimiento para la preparacion de alfa-halometil deriva- dos de amino acido Expired ES471594A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/819,975 US4315095A (en) 1977-07-28 1977-07-28 α-Halomethyl derivatives of amino acids

Publications (1)

Publication Number Publication Date
ES471594A1 true ES471594A1 (es) 1979-10-01

Family

ID=25229573

Family Applications (1)

Application Number Title Priority Date Filing Date
ES471594A Expired ES471594A1 (es) 1977-07-28 1978-07-10 Procedimiento para la preparacion de alfa-halometil deriva- dos de amino acido

Country Status (16)

Country Link
US (1) US4315095A (es)
JP (1) JPS5436262A (es)
AU (1) AU521354B2 (es)
BE (1) BE869322A (es)
CA (1) CA1120041A (es)
CH (1) CH638790A5 (es)
DE (1) DE2832309A1 (es)
ES (1) ES471594A1 (es)
FR (1) FR2398736A1 (es)
GB (1) GB2001626B (es)
IE (1) IE46928B1 (es)
IL (1) IL54914A0 (es)
IT (1) IT1107454B (es)
NL (1) NL7807871A (es)
NZ (1) NZ187537A (es)
ZA (1) ZA783350B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4413141A (en) * 1977-07-11 1983-11-01 Merrell Toraude Et Compagnie 2-(Difluoromethyl)-2,5-diaminopentanoic acid
JPS591490A (ja) * 1982-06-29 1984-01-06 Dai Ichi Seiyaku Co Ltd 3−セフェム−4−カルボン酸誘導体
CA1302919C (en) * 1985-07-03 1992-06-09 Robert T. Buckler Histamine derivatives, immunogen conjugates and antibodies raised thereto
US5030645A (en) * 1990-10-15 1991-07-09 Merck & Co., Inc. Method of treating asthma using (S)-α-fluoromethyl-histidine and esters thereof
US6001926A (en) * 1997-10-02 1999-12-14 The United States Of America As Represented By The Secretary Of The Navy Fiber-reinforced phthalonitrile composite cured with low-reactivity aromatic amine curing agent
EP1321169A1 (en) * 2001-12-18 2003-06-25 Biofrontera Pharmaceuticals AG Combination of a serotonin receptor antagonist with a histidine decarboxylase inhibitor as a medicament

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3169971A (en) * 1965-02-16 A-alkyl histidines
GB715182A (en) * 1951-09-19 1954-09-08 Roche Products Ltd A novel imidazole derivative and process for the manufacture thereof
FR1493402A (fr) * 1962-01-22 1967-09-01 Merck & Co Inc Hydrazino-acides
US3387031A (en) * 1961-06-08 1968-06-04 Union Carbide Corp Synthesis of alpha-amino acid amide hydrohalides
FR1457259A (fr) * 1961-08-18 1966-01-24 Merck & Co Inc Production d'amino-acides du type alpha-alkyl-histidine
NZ187377A (en) * 1977-06-01 1981-05-15 Merck & Co Inc A-amino-a-substituted alkyl-a-fluoromethylacetic acids

Also Published As

Publication number Publication date
IL54914A0 (en) 1978-08-31
GB2001626A (en) 1979-02-07
IT1107454B (it) 1985-11-25
JPS6123792B2 (es) 1986-06-07
FR2398736A1 (fr) 1979-02-23
AU3731778A (en) 1980-01-03
IT7850463A0 (it) 1978-07-25
CH638790A5 (de) 1983-10-14
CA1120041A (en) 1982-03-16
BE869322A (fr) 1978-11-16
FR2398736B1 (es) 1980-09-19
DE2832309A1 (de) 1979-02-08
JPS5436262A (en) 1979-03-16
ZA783350B (en) 1979-06-27
DE2832309C2 (es) 1989-07-06
IE781149L (en) 1979-01-28
IE46928B1 (en) 1983-11-02
AU521354B2 (en) 1982-04-01
US4315095A (en) 1982-02-09
GB2001626B (en) 1982-04-07
NZ187537A (en) 1980-08-26
NL7807871A (nl) 1979-01-30

Similar Documents

Publication Publication Date Title
ES455804A1 (es) Un procedimiento de preparacion de nuevos derivados del aci-do 3-quinolein- carboxilico.
ES467494A1 (es) Procedimiento para preparar derivados de fenoxibenciloxicar-bonilo.
ES8100276A1 (es) Un procedimiento para la preparacion de nuevos derivados de-4-anilinoquinazolinas
ES445702A1 (es) Procedimiento de preparacion de derivados de piridinio.
ES2126068T3 (es) Derivados de estilbeno citotoxicos y composicion farmaceutica que los contiene.
ES481065A1 (es) Procedimiento para la preparacion de nuevos eteres 3-hidroxidifenilicos halogenados.
IE811085L (en) Pyridoxine derivatives
ES472738A1 (es) Procedimiento para la obtencion de alfa-halometil derivados de aminas
TW360652B (en) Acryloyl substituted disstamycin derivatives, process for preparing them, and pharmaceutical composition comprising them
GB1544872A (en) 4-hydroxyphenylalkanolamine derivatives and preparation thereof
ES471594A1 (es) Procedimiento para la preparacion de alfa-halometil deriva- dos de amino acido
ES448175A1 (es) Procedimiento para la preparacion de propargil-2-fenilamino-imidazolinas-(2).
AU539870B2 (en) 2-phenylamino-imidazolines-(2)
ES454668A1 (es) Procedimiento para la preparacion de nuevas homoftalimidas.
GB2129425B (en) 5-halovinyl-2'-deoxyuridine derivatives
DE3361369D1 (en) Indanyl derivatives, their preparation and their use
CS572083A2 (en) Zpusob vyroby novych bazicky substituovanych 4 fenyl 4,5,6,7 tetrahydrothieno ( 2,3 c ) pyridinu
SE8002545L (sv) Arylsubstituerade furaner och sett for framstellning derav
ES437586A1 (es) Procedimiento para la produccion de un peptido.
DE3161263D1 (en) Thiazole derivatives, their preparation and use in therapeutics
IE782050L (en) Thieno-piperidines
ES451975A1 (es) Procedimiento para la preparacion de diesteres de tetrabro- moxilileno.
DE3464602D1 (en) 4-alkylimidazole derivatives, their preparation and their application
GB2011896A (en) Anthelmintic carbamic acid ester derivatives of benzimidazoles
ES462764A1 (es) Procedimiento para la obtencion de derivados de 1,6-anhidri-do-beta-d-hexopiranosa.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20001102